KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Depreciation & Amortization (IS)EBIATLeasesOther Gross PP&E AdjustmentsReceivables RefundsShares IssuedShares Outstanding
Ratios

Co-Diagnostics (CODX) Shares Repurchased (2022 - 2023)

Historic Shares Repurchased for Co-Diagnostics (CODX) over the last 2 years, with Q4 2023 value amounting to $159673.0.

  • Co-Diagnostics' Shares Repurchased fell 8688.51% to $159673.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $1.4 million, marking a year-over-year change of. This contributed to the annual value of $1.4 million for FY2023, which is 9040.29% down from last year.
  • As of Q4 2023, Co-Diagnostics' Shares Repurchased stood at $159673.0, which was down 8688.51% from $166326.0 recorded in Q3 2023.
  • In the past 5 years, Co-Diagnostics' Shares Repurchased registered a high of $10.4 million during Q3 2022, and its lowest value of $159673.0 during Q4 2023.